How long does a complete course of Telisotuzumab need to last?

Telisotuzumab (Telisotuzumab) is a targeted therapy drug mainly used to treat patients with c-Met positive non-small cell lung cancer. As an antibody drug conjugate (ADC), it accurately delivers cytotoxic drugs into cancer cells by targeting the c-Met receptor on the surface of tumor cells, thereby achieving effective killing. The duration of the complete course of treatment needs to be evaluated based on the patient's specific situation and clinical plan.

Generally speaking, the treatment cycle of territuzumab is usually "once every two weeks" as the dosing frequency. A complete course of treatment usually consists of multiple cycles of approximately 14 days each, and the treatment regimen may last several months. Based on clinical trials and actual treatment experience, patients generally need to continue taking medication for at least 4 to 6 cycles (about 2 to 3 months) to observe the therapeutic effect. During this period, doctors will evaluate whether to continue the medication or adjust the dose based on the patient's tumor response and tolerance.

In addition, the length of terituzumab treatment is affected by many factors, including tumor type, disease stage, patient's physical condition and treatment response. If the patient shows good tumor control and acceptable side effects during treatment, treatment may be extended for a longer period of time to maintain disease stability and prevent recurrence. On the other hand, if serious adverse reactions or poor efficacy occur, the doctor may recommend terminating treatment or switching to other options.

Finally, when patients receive terituzumab treatment, they should closely cooperate with their doctors for regular review and imaging evaluation, and provide timely feedback on their physical condition and discomfort symptoms. This will not only help doctors scientifically adjust treatment plans, but also help ensure patients’ medication safety and improve treatment effects. Overall, the duration of a complete course of territuzumab varies among individuals, but usually requires several months to achieve the best therapeutic effect.

Reference materials:https://www.drugs.com/